These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22854653)

  • 1. Temporal trends in the relative survival among women with cervical cancer in Canada: a population-based study.
    Akhtar-Danesh N; Elit L; Lytwyn A
    Int J Gynecol Cancer; 2012 Sep; 22(7):1208-13. PubMed ID: 22854653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal trends in the relative survival among patients diagnosed with ovarian cancer in Canada 1992-2005: a population-based study.
    Akhtar-Danesh N; Elit L; Lytwyn A
    Gynecol Oncol; 2011 Nov; 123(2):192-5. PubMed ID: 21855119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further insights into long-term trends in relative survival of vulvar cancer patients: a population-based study.
    Akhtar-Danesh N; Elit L; Lytwyn A
    Int J Gynecol Cancer; 2015 Jan; 25(1):125-30. PubMed ID: 25398020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
    Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
    Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in incidence and survival of women with invasive vulvar cancer in the United States and Canada: a population-based study.
    Akhtar-Danesh N; Elit L; Lytwyn A
    Gynecol Oncol; 2014 Aug; 134(2):314-8. PubMed ID: 24875124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, mortality and survival from invasive cervical cancer in Vaud, Switzerland, 1974-1991.
    Levi F; La Vecchia C; Randimbison L; Te VC
    Ann Oncol; 1994 Oct; 5(8):747-52. PubMed ID: 7826908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cervical cancer in the young woman].
    Marie G; Barjot P; Crouet H; Mace-Lesech J; Dommesent D; Uzan M
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(7):743-7. PubMed ID: 8308200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical carcinoma in a Muslim community.
    Badar F; Anwar N; Meerza F; Sultan F
    Asian Pac J Cancer Prev; 2007; 8(1):24-6. PubMed ID: 17477766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
    Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
    Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: a Gynecologic Oncology Group study.
    Waggoner SE; Darcy KM; Fuhrman B; Parham G; Lucci J; Monk BJ; Moore DH;
    Gynecol Oncol; 2006 Dec; 103(3):853-8. PubMed ID: 16815535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Support for down-staging of pregnancy-associated cervical cancer.
    Kärrberg C; Rådberg T; Holmberg E; Norström A
    Acta Obstet Gynecol Scand; 2015 Jun; 94(6):654-9. PubMed ID: 25845736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.
    Yokoi E; Mabuchi S; Takahashi R; Matsumoto Y; Kuroda H; Kozasa K; Kimura T
    J Gynecol Oncol; 2017 Mar; 28(2):e19. PubMed ID: 28028992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Twist enhances risk of poor oncologic outcome in patients with stage Ib to II cervical carcinoma with lymphovascular space involvement.
    Kajiyama H; Shibata K; Umezu T; Mizuno M; Suzuki S; Yamamoto E; Fujiwara S; Kikkawa F
    Hum Pathol; 2013 Feb; 44(2):181-8. PubMed ID: 22974479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of ABO blood group in patients with early stage cervical cancer treated with radical hysterectomy with pelvic node dissection.
    Hanprasertpong J; Jiamset I; Atjimakul T
    Tumour Biol; 2016 Jun; 37(6):7421-30. PubMed ID: 26678885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
    Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of gynecological cancers in Turkey: where are we at?
    Gultekin M; Dundar S; Kucukyildiz I; Karaca MZ; Boztas G; Turan SH; Hacikamiloglu E; Keskinkilic B
    J Gynecol Oncol; 2017 Nov; 28(6):e85. PubMed ID: 29027403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
    Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
    Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.